Expression of myogenic regulatory factors in normal and dystrophic mice: Effects of IGF-1 treatment

H. H. Hsu, Martin Zdanowicz, V. R. Agarwal, P. W. Speiser

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Myogenic regulatory factors (MRFs) promote differentiation of muscle cells from fibroblasts and are induced by insulin-like growth factor I (IGF- 1). Prior studies have shown synthesis of new muscle protein and improved muscle morphology when mature dy mice with muscular dystrophy are treated with IGF-1. We investigated whether these salutary effects of IGF-1 might be attributable to stimulation of MRFs. Male dy (129ReJ) mice and controls (129J) were assigned to IGF-1 treatment (10 μg twice daily) or nontreatment at about 5 weeks of life and sacrificed 6 weeks later. RNA was extracted from skeletal muscles, reverse transcribed, and amplified by polymerase chain reaction (PCR) using primers specific for each MRF. Competitive PCR was performed to quantify MyoD expression in response to IGF-1 treatment. Transcripts for myf-5, MRF4, and myogenin were detected in both control and dy mouse muscles; no apparent differences were observed between treatment groups. Quantitative analysis of transcripts for MyoD indicated no significant basal differences between control and dy mice. There was, however, significantly higher MyoD expression in the dy group, and a trend toward significance in the control group, following IGF-1 treatment. These data suggest that IGF-1 exerts its in vivo effects in postembryonal muscle by stimulating MRFs.

Original languageEnglish (US)
Pages (from-to)142-148
Number of pages7
JournalBiochemical and Molecular Medicine
Volume60
Issue number2
DOIs
StatePublished - Apr 1997
Externally publishedYes

Fingerprint

Myogenic Regulatory Factors
Insulin-Like Growth Factor I
Muscle
Polymerase chain reaction
Muscles
Myogenin
Polymerase Chain Reaction
Muscle Proteins
Muscular Dystrophies
Fibroblasts
Muscle Cells
Skeletal Muscle
Cells
RNA

ASJC Scopus subject areas

  • Biochemistry

Cite this

Expression of myogenic regulatory factors in normal and dystrophic mice : Effects of IGF-1 treatment. / Hsu, H. H.; Zdanowicz, Martin; Agarwal, V. R.; Speiser, P. W.

In: Biochemical and Molecular Medicine, Vol. 60, No. 2, 04.1997, p. 142-148.

Research output: Contribution to journalArticle

@article{8e63088714834c79b9701a97c876c876,
title = "Expression of myogenic regulatory factors in normal and dystrophic mice: Effects of IGF-1 treatment",
abstract = "Myogenic regulatory factors (MRFs) promote differentiation of muscle cells from fibroblasts and are induced by insulin-like growth factor I (IGF- 1). Prior studies have shown synthesis of new muscle protein and improved muscle morphology when mature dy mice with muscular dystrophy are treated with IGF-1. We investigated whether these salutary effects of IGF-1 might be attributable to stimulation of MRFs. Male dy (129ReJ) mice and controls (129J) were assigned to IGF-1 treatment (10 μg twice daily) or nontreatment at about 5 weeks of life and sacrificed 6 weeks later. RNA was extracted from skeletal muscles, reverse transcribed, and amplified by polymerase chain reaction (PCR) using primers specific for each MRF. Competitive PCR was performed to quantify MyoD expression in response to IGF-1 treatment. Transcripts for myf-5, MRF4, and myogenin were detected in both control and dy mouse muscles; no apparent differences were observed between treatment groups. Quantitative analysis of transcripts for MyoD indicated no significant basal differences between control and dy mice. There was, however, significantly higher MyoD expression in the dy group, and a trend toward significance in the control group, following IGF-1 treatment. These data suggest that IGF-1 exerts its in vivo effects in postembryonal muscle by stimulating MRFs.",
author = "Hsu, {H. H.} and Martin Zdanowicz and Agarwal, {V. R.} and Speiser, {P. W.}",
year = "1997",
month = "4",
doi = "10.1006/bmme.1997.2570",
language = "English (US)",
volume = "60",
pages = "142--148",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Expression of myogenic regulatory factors in normal and dystrophic mice

T2 - Effects of IGF-1 treatment

AU - Hsu, H. H.

AU - Zdanowicz, Martin

AU - Agarwal, V. R.

AU - Speiser, P. W.

PY - 1997/4

Y1 - 1997/4

N2 - Myogenic regulatory factors (MRFs) promote differentiation of muscle cells from fibroblasts and are induced by insulin-like growth factor I (IGF- 1). Prior studies have shown synthesis of new muscle protein and improved muscle morphology when mature dy mice with muscular dystrophy are treated with IGF-1. We investigated whether these salutary effects of IGF-1 might be attributable to stimulation of MRFs. Male dy (129ReJ) mice and controls (129J) were assigned to IGF-1 treatment (10 μg twice daily) or nontreatment at about 5 weeks of life and sacrificed 6 weeks later. RNA was extracted from skeletal muscles, reverse transcribed, and amplified by polymerase chain reaction (PCR) using primers specific for each MRF. Competitive PCR was performed to quantify MyoD expression in response to IGF-1 treatment. Transcripts for myf-5, MRF4, and myogenin were detected in both control and dy mouse muscles; no apparent differences were observed between treatment groups. Quantitative analysis of transcripts for MyoD indicated no significant basal differences between control and dy mice. There was, however, significantly higher MyoD expression in the dy group, and a trend toward significance in the control group, following IGF-1 treatment. These data suggest that IGF-1 exerts its in vivo effects in postembryonal muscle by stimulating MRFs.

AB - Myogenic regulatory factors (MRFs) promote differentiation of muscle cells from fibroblasts and are induced by insulin-like growth factor I (IGF- 1). Prior studies have shown synthesis of new muscle protein and improved muscle morphology when mature dy mice with muscular dystrophy are treated with IGF-1. We investigated whether these salutary effects of IGF-1 might be attributable to stimulation of MRFs. Male dy (129ReJ) mice and controls (129J) were assigned to IGF-1 treatment (10 μg twice daily) or nontreatment at about 5 weeks of life and sacrificed 6 weeks later. RNA was extracted from skeletal muscles, reverse transcribed, and amplified by polymerase chain reaction (PCR) using primers specific for each MRF. Competitive PCR was performed to quantify MyoD expression in response to IGF-1 treatment. Transcripts for myf-5, MRF4, and myogenin were detected in both control and dy mouse muscles; no apparent differences were observed between treatment groups. Quantitative analysis of transcripts for MyoD indicated no significant basal differences between control and dy mice. There was, however, significantly higher MyoD expression in the dy group, and a trend toward significance in the control group, following IGF-1 treatment. These data suggest that IGF-1 exerts its in vivo effects in postembryonal muscle by stimulating MRFs.

UR - http://www.scopus.com/inward/record.url?scp=0031127860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031127860&partnerID=8YFLogxK

U2 - 10.1006/bmme.1997.2570

DO - 10.1006/bmme.1997.2570

M3 - Article

C2 - 9169095

AN - SCOPUS:0031127860

VL - 60

SP - 142

EP - 148

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 2

ER -